NioCorp's 2022 NPV Wasn't the Problem-Financing Is the Real Hurdle

The 2022 study settled the valuation case; financing is now the key decision

The valuation debate is no longer about the geology. The 2022 feasibility study delivered a $2.819 billion pre-tax NPV, which left investors focused elsewhere. Right now, the main question is whether NioCorp can follow through on its Q2 2026 financing target.

Bulls have reasons for confidence. NioCorp entered 2026 with more than $300 million in cash, accelerated EXIM Bank engagement, 75% of niobium under offtake, and firmer non-Chinese rare earth prices. Those factors could improve project economics versus the original study. But they still do not equal committed project funding. That is why financing, not resource quality, is now the stock's main hinge.

If financing closes on schedule, Elk Creek can move from an attractive plan to a de-risked development story. If it slips, the market will likely stop rewarding the strategic narrative and focus on the timing gap instead.

Why strong project economics can still fail at the financing stage

The 2022 study already made the valuation case look compelling. What can still derail the stock is the financing decision, because that is where optimism can outrun hard commitments.

The $780 million financing decision is the real stress test

At $780 million of targeted project financing, structured as 65% debt and 35% equity, the story shifts from technical merit to capital structure. A positive study can make the upside feel obvious, but lenders still need to be convinced on timing, downside protection, and execution risk.

In critical minerals, strategic importance can drive a rally before funding is fully in place. That can work for a while, but it becomes a problem if investors start pricing commitment before it is actually secured.

Niobium and scandium help the case; rare earths are still optionality

The project is centered on niobium, with management highlighting strong demand growth. Scandium also offers meaningful long-term demand potential in aviation and automotive applications. That gives the project room to rerate once financing is in place.

Investors should be more cautious about leaning too hard on rare earths. The 2022 feasibility study said REEs could be produced as a byproduct once project financing is secured, and recovery still depends on metallurgical testing at a demonstration plant in Quebec. For now, that is better treated as optionality than as a base-case assumption.

Watch financing proof, not just the strategic story

Until financing becomes binding, this is still a catalyst-driven story rather than a producer story.

The next concrete update is the April 2026 annual meeting

The near-term watchlist starts with the 2025 Annual General Meeting of Shareholders on Monday, April 6, 2026. The key question is whether management can give a specific update on financing progress, not whether it can reinforce the broader critical-minerals narrative.

After that, the most important institutional marker is whether the company shows progress toward binding commitments from the US Export-Import Bank. If those markers advance cleanly, the market can keep treating Elk Creek as a project moving toward construction. If they stall, the timeline is likely to lose credibility.